🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

BRIEF-Valeant says Michael Pearson 2015 total compensation $143.1 mln

Published 2016-04-29, 11:14 a/m
© Reuters.  BRIEF-Valeant says Michael Pearson 2015 total compensation $143.1 mln
PSON
-
BHC
-

April 29 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc VRX.TO
* J. Michael Pearson (LON:PSON) 2015 total compensation of $143.1
million versus $10.4 million in 2014
* Says CFO Robert L. Rosiello FY 2015 total compensation
$60.4 million - SEC filing
* Group chairman Ari Kellen's FY 2015 total compensation was
$4.7 million versus $50.64 million
* Group chairman Ari Kellen's FY 2014 total compensation
includes $43.1 million of stock awards
* Howard Schiller's total 2015 compensation $606,805 versus
$27.1 million in 2014
* Valeant Pharmaceuticals says Pearson 2015 total
compensation includes $140.3 million of stock awards
* Howard Schiller's total 2014 compensation includes $23.7
million of stock awards
* Valeant Pharmaceuticals says Pearson 2015 total
compensation of $143.1 million includes $2 million of non equity
incentive plan compensation

Source - http://1.usa.gov/1Ta1a4e
Further company coverage: VRX.TO

(Bengaluru Newsroom; +1 646 223 8780)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.